Millions more adults should consider starting cholesterol-lowering medications earlier to reduce their risk of heart attack ...

The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia-abnormal ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation that all adults be tested once for lipoprotein(a), a genetic risk marker ...

Major medical organizations updated the cholesterol playbook for the first time in years, with new risk tools, lower targets and earlier treatment recommendations.

The problem starts with how doctors typically test for heart disease. Traditional lipid panels focus on cholesterol—a waxy substance that can build up in arteries—and triglycerides, a type of fat that ...

High cholesterol can cause fatigue by reducing blood flow, increasing heart strain, triggering inflammation, and medication side effects.

A recent study published in Engineering has shed new light on the relationship between cholesterol levels and mortality risks.

Discover how low cholesterol levels might actually pose health risks! A new study in Engineering reveals that both low and decreasing cholesterol levels are linked to higher mortality risks, ...

TORONTO, March 5, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and ...

Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.